Cases 81 - 90 of 197
MERCK SHARP & DOHME B.V. et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2020cv02576
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Plaintiff:
ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. AUROBINDO PHARMA LIMITED et al
as 2:2020cv00315
Defendant:
AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LIMITED, AUROLIFE PHARMA LLC and others
Plaintiff:
CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1126
Allergan USA, Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2019cv02317
Plaintiff:
Allergan USA, Inc., Allergan Sales, LLC, Forest Laboratories Holdings Limited and others
Defendant:
Sun Pharmaceutical Industries Limited, Cadila Healthcare Limited, Aurobindo Pharma USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc.
as 1:2019cv02197
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
Aziende Chimiche Riunite Angelini Francesco ACRAFSpA
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Aurobindo Pharma USA Inc.
as 1:2019cv02113
Defendant:
Aurobindo Pharma USA Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Arena Pharmaceuticals, Inc. et al v. Aurobindo Pharma Limited et al
as 1:2019cv00811
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Eisai Inc., 356 Royalty Inc. and Arena Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
CHIESI USA, INC. et al v. AUROBINDO PHARMA USA, INC. et al
as 3:2019cv18756
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Plaintiff:
CHIESI USA, INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01862
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
